Matthew Robert Sydes (Matthew R Sydes, Matthew Sydes)

ORCID

Publication Activity (10 Years)

Years Active: 2014-2024
Publications (10 Years): 59

Top Venues

Clinical trials (London, England)

BMJ open

Trials

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

University College London

University of Greenwich (MSC)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University College London Oct 01 2019

United Kingdom

Professor of Clinical Trials and Methodology :: MRC Clinical Trials Unit at UCL

University College London - Sep 30 2020

United Kingdom

Reader in Clinical Trials, Senior Scientist, Senior Statistician :: MRC Clinical Trials Unit at UCL

Education History

University of Greenwich

United Kingdom

MSC

University of Sussex

United Kingdom

BSC :: School of Biological Sciences

Publications

Yang Chen, Anoop Shah, Yogini H Jani, Daniel Higgins, Nausheen Saleem, Kris Chafer, Matthew Robert Sydes, Folkert W Asselbergs, R Thomas Lumbers
Rationale and design of the THIRST Alert feasibility study: a pragmatic, single-centre, parallel-group randomised controlled trial of an interruptive alert for oral fluid restriction in patients treated with intravenous furosemide. BMJ open 14 (1) (2024)
Yang Chen, Anoop Shah, Yogini H Jani, Daniel Higgins, Nausheen Saleem, Kris Chafer, Matthew Robert Sydes, Folkert W Asselbergs, R Thomas Lumbers
Rationale and design of the THIRST Alert feasibility study: a pragmatic, single-centre, parallel-group randomised controlled trial of an interruptive alert for oral fluid restriction in patients treated with intravenous furosemide. BMJ open 14 (1) (2024)
Lucia Kwak, Praful Ravi, John G Armstrong, Veronique Beckendorf, Joseph L Chin, Anthony V D'Amico, David P Dearnaley, Savino M Di Stasi, Silke Gillessen Sommer, Himanshu Lukka, Nicolas Mottet, Pascal Pommier, Wendy Seiferheld, Matthew Robert Sydes, Bertrand Tombal, Almudena Zapatero, Meredith M Regan, Wanling Xie, Christopher J Sweeney
Prognostic Impact of Prostate-Specific Antigen at 6 Months After Radiotherapy in Localized Prostate Cancer: An Individual Patient Data Analysis of Randomized Trials. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (18) (2024)
Lucia Kwak, Praful Ravi, John G Armstrong, Veronique Beckendorf, Joseph L Chin, Anthony V D'Amico, David P Dearnaley, Savino M Di Stasi, Silke Gillessen Sommer, Himanshu Lukka, Nicolas Mottet, Pascal Pommier, Wendy Seiferheld, Matthew Robert Sydes, Bertrand Tombal, Almudena Zapatero, Meredith M Regan, Wanling Xie, Christopher J Sweeney
Prognostic Impact of Prostate-Specific Antigen at 6 Months After Radiotherapy in Localized Prostate Cancer: An Individual Patient Data Analysis of Randomized Trials. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (18) (2024)
Yang Chen, Anoop Shah, Yogini H Jani, Daniel Higgins, Nausheen Saleem, Kris Chafer, Matthew Robert Sydes, Folkert W Asselbergs, R Thomas Lumbers
Rationale and design of the THIRST Alert feasibility study: a pragmatic, single-centre, parallel-group randomised controlled trial of an interruptive alert for oral fluid restriction in patients treated with intravenous furosemide. BMJ open 14 (1) (2024)
Yang Chen, Anoop Shah, Yogini H Jani, Daniel Higgins, Nausheen Saleem, Kris Chafer, Matthew Robert Sydes, Folkert W Asselbergs, R Thomas Lumbers
Rationale and design of the THIRST Alert feasibility study: a pragmatic, single-centre, parallel-group randomised controlled trial of an interruptive alert for oral fluid restriction in patients treated with intravenous furosemide. BMJ open 14 (1) (2024)
Yang Chen, Anoop Shah, Yogini H Jani, Daniel Higgins, Nausheen Saleem, Kris Chafer, Matthew Robert Sydes, Folkert W Asselbergs, R Thomas Lumbers
Rationale and design of the THIRST Alert feasibility study: a pragmatic, single-centre, parallel-group randomised controlled trial of an interruptive alert for oral fluid restriction in patients treated with intravenous furosemide. BMJ open 14 (1) (2024)
Yang Chen, Anoop Shah, Yogini H Jani, Daniel Higgins, Nausheen Saleem, Kris Chafer, Matthew Robert Sydes, Folkert W Asselbergs, R Thomas Lumbers
Rationale and design of the THIRST Alert feasibility study: a pragmatic, single-centre, parallel-group randomised controlled trial of an interruptive alert for oral fluid restriction in patients treated with intravenous furosemide. BMJ open 14 (1) (2024)
Lucia Kwak, Praful Ravi, John G Armstrong, Veronique Beckendorf, Joseph L Chin, Anthony V D'Amico, David P Dearnaley, Savino M Di Stasi, Silke Gillessen Sommer, Himanshu Lukka, Nicolas Mottet, Pascal Pommier, Wendy Seiferheld, Matthew Robert Sydes, Bertrand Tombal, Almudena Zapatero, Meredith M Regan, Wanling Xie, Christopher J Sweeney
Prognostic Impact of Prostate-Specific Antigen at 6 Months After Radiotherapy in Localized Prostate Cancer: An Individual Patient Data Analysis of Randomized Trials. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Macey L Murray, Laura Sato, Jaspal Panesar, Sharon B Love, Rebecca Lee, James R Carpenter, Marion Mafham, Mahesh K B Parmar, Heather Pinches, Matthew Robert Sydes
Demonstrating the data integrity of routinely collected healthcare systems data for clinical trials (DEDICaTe): A proof-of-concept study. Health informatics journal 30 (3) (2024)
Shao-Fan Hsieh, Victoria Yorke-Edwards, Macey L Murray, Carlos Diaz-Montana, Sharon B Love, Matthew Robert Sydes
Lack of transparent reporting of trial monitoring approaches in randomised controlled trials: A systematic review of contemporary protocol papers. Clinical trials (London, England) (2023)
Shao-Fan Hsieh, Victoria Yorke-Edwards, Macey L Murray, Carlos Diaz-Montana, Sharon B Love, Matthew Robert Sydes
Lack of transparent reporting of trial monitoring approaches in randomised controlled trials: A systematic review of contemporary protocol papers. Clinical trials (London, England) (2023)
Annabelle South, Julia Bailey, Barbara E Bierer, Eva Burnett, William J Cragg, Carlos Diaz-Montana, Katie Gillies, Talia Isaacs, Nalinie Joharatnam-Hogan, Claire Snowdon, Matthew Robert Sydes, Andrew J Copas
Site staff perspectives on communicating trial results to participants: Cost and feasibility results from the Show RESPECT cluster randomised, factorial, mixed-methods trial. Clinical trials (London, England) (2023)
Shao-Fan Hsieh, Victoria Yorke-Edwards, Macey L Murray, Carlos Diaz-Montana, Sharon B Love, Matthew Robert Sydes
Lack of transparent reporting of trial monitoring approaches in randomised controlled trials: A systematic review of contemporary protocol papers. Clinical trials (London, England) 20 (2) (2023)
Megan McCarthy, Katie Gillies, Nikki Rousseau, Julia Wade, Carrol Gamble, Elaine C Toomey, Karen Matvienko-Sikar, Matthew Robert Sydes, Maura Dowling, Valerie Bryant, Linda M Biesty, Catherine Houghton
Qualitative data sharing practices in clinical trials in the UK and Ireland: towards the production of good practice guidance. HRB open research 6 (2023)
Shao-Fan Hsieh, Victoria Yorke-Edwards, Macey L Murray, Carlos Diaz-Montana, Sharon B Love, Matthew Robert Sydes
Lack of transparent reporting of trial monitoring approaches in randomised controlled trials: A systematic review of contemporary protocol papers. Clinical trials (London, England) 20 (2) (2023)
Shao-Fan Hsieh, Victoria Yorke-Edwards, Macey L Murray, Carlos Diaz-Montana, Sharon B Love, Matthew Robert Sydes
Lack of transparent reporting of trial monitoring approaches in randomised controlled trials: A systematic review of contemporary protocol papers. Clinical trials (London, England) (2023)
Gerhardt Attard, Marina Parry, Emily Grist, Larissa Mendes, Peter Dutey-Magni, Ashwin Sachdeva, Christopher Brawley, Laura Murphy, James Proudfoot, Sharanpreet Lall, Yang Liu, Stefanie Friedrich, Mazlina Ismail, Alex Hoyle, Adnan Ali, Aine Haran, Anna Wingate, Leila Zakka, Daniel Wetterskog, Claire Amos, Nafisah Atako, Victoria Wang, Hannah Rush, Robert Jones, Hing Y Leung, William Cross, Silke Gillessen Sommer, Chris Parker, Simon Chowdhury, Tamara L Lotan, Teresa Marafioti, Alfonso Urbanucci, Edward M Schaeffer, Daniel Spratt, David Waugh, Thomas Powles, Daniel Berney, Matthew Robert Sydes, Mahesh Parmar, Anis Hamid, Felix Y Feng, Christopher Sweeney, Elai Davicioni, Noel Clarke, Nicholas James, Louise Brown
Clinical testing of transcriptome-wide expression profiles in high-risk localized and metastatic prostate cancer starting androgen deprivation therapy: an ancillary study of the STAMPEDE abiraterone Phase 3 trial. Research square (2023)
Shao-Fan Hsieh, Victoria Yorke-Edwards, Macey L Murray, Carlos Diaz-Montana, Sharon B Love, Matthew Robert Sydes
Lack of transparent reporting of trial monitoring approaches in randomised controlled trials: A systematic review of contemporary protocol papers. Clinical trials (London, England) 20 (2) (2023)
Gerhardt Attard, Marina Parry, Emily Grist, Larissa Mendes, Peter Dutey-Magni, Ashwin Sachdeva, Christopher Brawley, Laura Murphy, James Proudfoot, Sharanpreet Lall, Yang Liu, Stefanie Friedrich, Mazlina Ismail, Alex Hoyle, Adnan Ali, Aine Haran, Anna Wingate, Leila Zakka, Daniel Wetterskog, Claire Amos, Nafisah Atako, Victoria Wang, Hannah Rush, Robert Jones, Hing Y Leung, William Cross, Silke Gillessen Sommer, Chris Parker, Simon Chowdhury, Tamara L Lotan, Teresa Marafioti, Alfonso Urbanucci, Edward M Schaeffer, Daniel Spratt, David Waugh, Thomas Powles, Daniel Berney, Matthew Robert Sydes, Mahesh Parmar, Anis Hamid, Felix Y Feng, Christopher Sweeney, Elai Davicioni, Noel Clarke, Nicholas James, Louise Brown
Clinical testing of transcriptome-wide expression profiles in high-risk localized and metastatic prostate cancer starting androgen deprivation therapy: an ancillary study of the STAMPEDE abiraterone Phase 3 trial. Research square (2023)
Soumyajit Roy, Tahmineh Romero, Jeff M Michalski, Felix Y Feng, Jason Alexander Efstathiou, Colleen A F Lawton, Michel Bolla, Philippe Maingon, Theo de Reijke, David Joseph, Wee Loon Ong, Matthew Robert Sydes, David P Dearnaley, Alison C Tree, Nathalie Carrier, Abdenour Nabid, Luis Souhami, Luca Incrocci, Wilma D Heemsbergen, Floris J Pos, Almudena Zapatero, Araceli Guerrero, Ana Alvarez, Carmen Gonzalez San-Segundo, Xavier Maldonado, Robert E Reiter, Matthew B Rettig, Nicholas G Nickols, Michael L Steinberg, Luca F Valle, Ting Martin Ma, Matthew J Farrell, Beth K Neilsen, Jesus E Juarez, Jie Deng, Sitaram Vangala, Norbert Avril, Angela Y Jia, Nicholas G Zaorsky, Yilun Sun, Daniel E Spratt, Amar U Kishan, null null
Biochemical Recurrence Surrogacy for Clinical Outcomes After Radiotherapy for Adenocarcinoma of the Prostate. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Shao-Fan Hsieh, Victoria Yorke-Edwards, Macey L Murray, Carlos Diaz-Montana, Sharon B Love, Matthew Robert Sydes
Lack of transparent reporting of trial monitoring approaches in randomised controlled trials: A systematic review of contemporary protocol papers. Clinical trials (London, England) 20 (2) (2023)
Nicholas D James, Fiona C Ingleby, Noel W Clarke, Claire L Amos, Gerhardt Attard, Christopher D Brawley, Simon Chowdhury, William R Cross, David P Dearnaley, Duncan C Gilbert, Silke Gillessen Sommer, Robert J Jones, Ruth E Langley, Archie Macnair, Zafar I Malik, Malcolm D Mason, David J Matheson, Robin Millman, Chris C Parker, Hannah L Rush, J Martin Russell, Carly Au, Alastair W S Ritchie, Ricardo Pereira Mestre, Imtiaz Ahmed, Alison Jane Birtle, Susannah J Brock, Prantik Das, Victoria A Ford, Emma K Gray, Robert J Hughes, Caroline B Manetta, Duncan B McLaren, Ashok D Nikapota, Joe M O'Sullivan, Carla Perna, Clive Peedell, Andrew S Protheroe, Santhanam Sundar, Jacob S Tanguay, Shaun P Tolan, John Wagstaff, Jan B Wallace, James P Wylie, Anjali Zarkar, Mahesh K B Parmar, Matthew Robert Sydes
Docetaxel for Nonmetastatic Prostate Cancer: Long-Term Survival Outcomes in the STAMPEDE Randomized Controlled Trial. JNCI cancer spectrum 6 (4) (2022)
Nicholas D James, Noel W Clarke, Adrian D Cook, Adnan Ali, Alex P Hoyle, Gerhardt Attard, Christopher D Brawley, Simon Chowdhury, William R Cross, David P Dearnaley, Johann S de Bono, Carlos Diaz-Montana, Duncan C Gilbert, Silke Gillessen Sommer, Clare Gilson, Robert J Jones, Ruth E Langley, Zafar I Malik, David J Matheson, Robin Millman, Chris C Parker, Cheryl Pugh, Hannah L Rush, J Martin Russell, Dominik R Berthold, Michelle L Buckner, Malcolm D Mason, Alastair W S Ritchie, Alison Jane Birtle, Susannah J Brock, Prantik Das, Dan Ford, Joanna Gale, Warren Grant, Emma K Gray, Peter J Hoskin, Mohammad M Khan, Caroline Manetta, Neil J McPhail, Joe M O'Sullivan, Omi Parikh, Carla Perna, Carmel J Pezaro, Andrew S Protheroe, Angus J Robinson, Sarah M Rudman, Denise J Sheehan, Narayanan N Srihari, Isabel Syndikus, Jacob S Tanguay, Carys W Thomas, Salil Vengalil, John Wagstaff, James P Wylie, Mahesh K B Parmar, Matthew Robert Sydes, null null
Abiraterone acetate plus prednisolone for metastatic patients starting hormone therapy: 5-year follow-up results from the STAMPEDE randomised trial (NCT00268476). International journal of cancer 151 (3) (2022)
James M S Wason, Munyaradzi Dimairo, Katie Biggs, Sarah Bowden, Julia M Brown, Laura Flight, Jamie Hall, Thomas F Jaki, Rachel Lowe, Philip Pallmann, Mark A Pilling, Claire Snowdon, Matthew Robert Sydes, Sofía S Villar, Christopher J Weir, Nina Wilson, Christina Yap, Helen C Hancock, Rebecca H Maier
Practical guidance for planning resources required to support publicly-funded adaptive clinical trials. BMC medicine 20 (1) (2022)
Victoria Yorke-Edwards, Carlos Diaz-Montana, Macey L Murray, Matthew Robert Sydes, Sharon B Love
Monitoring metrics over time: Why clinical trialists need to systematically collect site performance metrics. Research methods in medicine & health sciences 4 (4) (2022)
Chris C Parker, Nicholas D James, Christopher D Brawley, Noel W Clarke, Adnan Ali, Claire L Amos, Gerhardt Attard, Simon Chowdhury, Adrian D Cook, William R Cross, David P Dearnaley, Hassan Douis, Duncan C Gilbert, Clare Gilson, Silke Gillessen Sommer, Alex Hoyle, Robert J Jones, Ruth E Langley, Zafar I Malik, Malcolm D Mason, David J Matheson, Robin Millman, Mary Rauchenberger, Hannah L Rush, J Martin Russell, Hannah Sweeney, Amit Bahl, Alison Jane Birtle, Lisa Capaldi, Omar Din, Daniel Ford, Joanna Gale, Ann Henry, Peter J Hoskin, Mohammed Kagzi, Anna Lydon, Joe M O'Sullivan, Sangeeta A Paisey, Omi Parikh, Delia Pudney, Vijay Ramani, Peter Robson, Narayanan Nair Srihari, Jacob S Tanguay, Mahesh K B Parmar, Matthew Robert Sydes, null null
Radiotherapy to the prostate for men with metastatic prostate cancer in the UK and Switzerland: Long-term results from the STAMPEDE randomised controlled trial. PLoS medicine 19 (6) (2022)
Nurulamin M Noor, Sharon B Love, Talia Isaacs, Richard Kaplan, Mahesh K B Parmar, Matthew Robert Sydes
Uptake of the multi-arm multi-stage (MAMS) adaptive platform approach: a trial-registry review of late-phase randomised clinical trials. BMJ open 12 (3) (2022)
Matthew Robert Sydes, Wai Keong Wong, Ameet Bakhai, Nicola Joffe, Sharon B Love
Protecting blinded trials in electronic hospital systems. Clinical trials (London, England) 19 (2) (2022)
Ian R White, Babak Choodari-Oskooei, Matthew Robert Sydes, Brennan C Kahan, Leanne McCabe, Anna Turkova, Hanif Esmail, Diana M Gibb, Deborah Ford
Combining factorial and multi-arm multi-stage platform designs to evaluate multiple interventions efficiently. Clinical trials (London, England) 19 (4) (2022)
Ting Martin Ma, Yilun Sun, Shawn Malone, Mack Roach, David P Dearnaley, Thomas M Pisansky, Felix Y Feng, Howard M Sandler, Jason Alexander Efstathiou, Isabel Syndikus, Emma C Hall, Alison C Tree, Matthew Robert Sydes, Claire Cruickshank, Soumyajit Roy, Michel Bolla, Philippe Maingon, Theo De Reijke, Abdenour Nabid, Nathalie Carrier, Luis Souhami, Almudena Zapatero, Araceli Guerrero, Ana Alvarez, Carmen Gonzalez San-Segundo, Xavier Maldonado, Tahmineh Romero, Michael L Steinberg, Luca F Valle, Matthew B Rettig, Nicholas G Nickols, Jonathan E Shoag, Robert E Reiter, Nicholas G Zaorsky, Angela Y Jia, Jorge A Garcia, Daniel E Spratt, Amar U Kishan, null null
Sequencing of Androgen-Deprivation Therapy of Short Duration With Radiotherapy for Nonmetastatic Prostate Cancer (SANDSTORM): A Pooled Analysis of 12 Randomized Trials. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2022)
Caroline S Clarke, Rachael M Hunter, Andrea Gabrio, Christopher D Brawley, Fiona C Ingleby, David P Dearnaley, David J Matheson, Gerhardt Attard, Hannah L Rush, Robert J Jones, William Cross, Chris Parker, J Martin Russell, Robin Millman, Silke Gillessen, Zafar Malik, Jason F Lester, James Wylie, Noel W Clarke, Mahesh K B Parmar, Matthew Robert Sydes, Nicholas D James
Cost-utility analysis of adding abiraterone acetate plus prednisone/prednisolone to long-term hormone therapy in newly diagnosed advanced prostate cancer in England: Lifetime decision model based on STAMPEDE trial data. PloS one 17 (6) (2022)
Catherine Houghton, Megan McCarthy, Katie Gillies, Nikki Rousseau, Julia Wade, Carrol Gamble, Elaine C Toomey, Karen Matvienko-Sikar, Matthew Robert Sydes, Maura Dowling, Valerie Bryant, Linda M Biesty
A study protocol of qualitative data sharing practices in clinical trials in the UK and Ireland: towards the production of good practice guidance. HRB open research 4 (2021)
Matthew Robert Sydes, Yolanda Barbachano, Louise Bowman, Tom Denwood, Andrew J Farmer, Steph Garfield-Birkbeck, J Martin Gibson, Martin C Gulliford, David A Harrison, Catherine Elizabeth Hewitt, Jennifer Logue, Will Navaie, John Dt Norrie, Martin O'Kane, Jennifer Kathleen Quint, Joanne Rycroft-Malone, Jonathan Sheffield, Liam Smeeth, Frank M Sullivan, Juliet Tizzard, Paula Walker, John P H Wilding, Paula R Williamson, Martin J Landray, Andrew D Morris, Rhoswyn R Walker, Hywel C Williams, Janet Valentine, null null
Realising the full potential of data-enabled trials in the UK: a call for action. BMJ open 11 (6) (2021)
Sharon B Love, Victoria Yorke-Edwards, Carlos Diaz-Montana, Macey L Murray, Lindsey Masters, Michelle M Gabriel, Nicola Joffe, Matthew Robert Sydes
Making a distinction between data cleaning and central monitoring in clinical trials. Clinical trials (London, England) 18 (3) (2021)
Archie Macnair, Sharon B Love, Macey L Murray, Duncan C Gilbert, Mahesh K B Parmar, Tom Denwood, James R Carpenter, Matthew Robert Sydes, Ruth E Langley, Fay H Cafferty
Accessing routinely collected health data to improve clinical trials: recent experience of access. Trials 22 (1) (2021)
Megan McCarthy, Linda O'Keeffe, Paula R Williamson, Matthew Robert Sydes, Amanda Farrin, Fiona V Lugg-Widger, Gwyneth Davies, Kerry Avery, An-Wen Chan, Linda Kwakkenbos, Brett D Thombs, Alan Watkins, Lars G Hemkens, Chris Gale, Merrick Zwarenstein, Sinéad M Langan, Lehana Thabane, Edmund Juszczak, David Moher, Patricia M Kearney
A study protocol for the development of a SPIRIT extension for trials conducted using cohorts and routinely collected data (SPIRIT-ROUTINE). HRB open research 4 (2021)
Sharon B Love, Anna Kilanowski, Victoria Yorke-Edwards, Oliver Old, Hugh Barr, Clive Stokes, Catherine Kendall, Matthew Robert Sydes
Use of routinely collected health data in randomised clinical trials: comparison of trial-specific death data in the BOSS trial with NHS Digital data. Trials 22 (1) (2021)
Annabelle South, Nalinie Joharatnam-Hogan, Cara Purvis, Elizabeth C James, Carlos Diaz-Montana, William J Cragg, Conor D Tweed, Archie Macnair, Matthew Robert Sydes, Claire Snowdon, Katie Gillies, Talia Isaacs, Barbara E Bierer, Andrew J Copas
Testing approaches to sharing trial results with participants: The Show RESPECT cluster randomised, factorial, mixed methods trial. PLoS medicine 18 (10) (2021)
Hannah L Rush, Laura Murphy, Alicia K Morgans, Noel W Clarke, Adrian D Cook, Gerhardt Attard, Archie Macnair, David P Dearnaley, Christopher C Parker, J Martin Russell, Silke Gillessen Sommer, David J Matheson, Robin Millman, Christopher D Brawley, Cheryl Pugh, Jacob S Tanguay, Robert J Jones, John Wagstaff, Sarah Rudman, Joe M O'Sullivan, Joanna Gale, Alison Jane Birtle, Andrew S Protheroe, Emma Gray, Carla Perna, Shaun Tolan, Neil McPhail, Zaf I Malik, Salil Vengalil, David Fackrell, Peter J Hoskin, Matthew Robert Sydes, Simon Chowdhury, Duncan C Gilbert, Mahesh K B Parmar, Nicholas D James, Ruth E Langley
Quality of Life in Men With Prostate Cancer Randomly Allocated to Receive Docetaxel or Abiraterone in the STAMPEDE Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2021)
Sharon B Love, Victoria Yorke-Edwards, Sarah Lensen, Matthew Robert Sydes
Monitoring in practice - How are UK academic clinical trials monitored? A survey. Trials 21 (1) (2020)
Babak Choodari-Oskooei, Daniel J Bratton, Melissa R Gannon, Angela M Meade, Matthew Robert Sydes, Mahesh Kb Parmar
Adding new experimental arms to randomised clinical trials: Impact on error rates. Clinical trials (London, England) 17 (3) (2020)
Nurulamin M Noor, Sarah L Pett, Hanif Esmail, Angela M Crook, Claire L Vale, Matthew Robert Sydes, Mahesh K B Parmar
Adaptive platform trials using multi-arm, multi-stage protocols: getting fast answers in pandemic settings. F1000Research (2020)
Nurulamin M Noor, Sarah L Pett, Hanif Esmail, Angela M Crook, Claire L Vale, Matthew Robert Sydes, Mahesh K B Parmar
Adaptive platform trials using multi-arm, multi-stage protocols: getting fast answers in pandemic settings. F1000Research 9 (2020)
Sarah Lensen, Archie Macnair, Sharon B Love, Victoria Yorke-Edwards, Nurulamin M Noor, Meredith Martyn, Alexandra Blenkinsop, Carlos Diaz-Montana, Graham Powell, Elizabeth J Williamson, James R Carpenter, Matthew Robert Sydes
Access to routinely collected health data for clinical trials - review of successful data requests to UK registries. Trials 21 (1) (2020)
Elizabeth C James, David T Dunn, Adrian D Cook, Andrew R Clamp, Matthew Robert Sydes
Overlap between adverse events (AEs) and serious adverse events (SAEs): a case study of a phase III cancer clinical trial. Trials 21 (1) (2020)
Gabriele Calaminus, Meriel Jenney, Lars Hjorth, Katja Baust, Mark Bernstein, Stefan S Bielack, Patricia De Vos, Pancras C W Hogendoorn, Gordana Jovic, Mark Krailo, Kiana Kreitz, Neyssa M Marina, Babasola O Popoola, Cristina Sauerland, Sigbjørn Smeland, Carmen Teske, Clara V Schweinitz, Jeremy S Whelan, Andreas Wiener, Matthew Robert Sydes, Rajaram Nagarajan
Quality of Life of Patients With Osteosarcoma in the European American Osteosarcoma Study-1 (EURAMOS-1): Development and Implementation of a Questionnaire Substudy. JMIR research protocols 8 (8) (2019)
Carlo Lancia, Jakob K Anninga, Matthew Robert Sydes, Cristian Spitoni, Jeremy S Whelan, Pancras C W Hogendoorn, André B P van Kuilenburg, Marta Fiocco
A novel method to address the association between received dose intensity and survival outcome: benefits of approaching treatment intensification at a more individualised level in a trial of the European Osteosarcoma Intergroup. Cancer chemotherapy and pharmacology 83 (5) (2019)
Andrew Embleton-Thirsk, Elizabeth Deane, Stephen Townsend, Laura Farrelly, Babasola Popoola, Judith Parker, Gordon Rustin, Matthew Robert Sydes, Mahesh Parmar, Jonathan Ledermann, Richard Kaplan
Impact of retrospective data verification to prepare the ICON6 trial for use in a marketing authorization application. Clinical trials (London, England) 16 (5) (2019)
Francesca Schiavone, Riya Bathia, Krishna Letchemanan, Lindsey Masters, Claire Amos, Anna Bara, Louise C Brown, Clare Gilson, Cheryl Pugh, Nafisah Atako, Fleur Hudson, Mahesh K B Parmar, Ruth E Langley, Richard S Kaplan, Chris Parker, Gert Attard, Noel W Clarke, Silke Gillessen, Nicholas D James, Tim Maughan, Matthew Robert Sydes, null null
This is a platform alteration: a trial management perspective on the operational aspects of adaptive and platform and umbrella protocols. Trials 20 (1) (2019)
Carlos Diaz-Montana, William J Cragg, Rahela Choudhury, Nicola Joffe, Matthew Robert Sydes, Sally P Stenning
Implementing monitoring triggers and matching of triggered and control sites in the TEMPER study: a description and evaluation of a triggered monitoring management system. Trials 20 (1) (2019)
Dominic Hague, Stephen Townsend, Lindsey Masters, Mary Rauchenberger, Nadine Van Looy, Carlos Diaz-Montana, Melissa Ruth Gannon, Nicholas D James, Tim Maughan, Mahesh K B Parmar, Louise C Brown, Matthew Robert Sydes, null null
Changing platforms without stopping the train: experiences of data management and data management systems when adapting platform protocols by adding and closing comparisons. Trials 20 (1) (2019)
Carlo Lancia, Jakob Anninga, Cristian Spitoni, Matthew Robert Sydes, Jeremy Whelan, Pancras C W Hogendoorn, Hans Gelderblom, Marta Fiocco
Method to measure the mismatch between target and achieved received dose intensity of chemotherapy in cancer trials: a retrospective analysis of the MRC BO06 trial in osteosarcoma. BMJ open 9 (5) (2019)
Tim P Morris, Christopher I Jarvis, William J Cragg, Patrick Peter John Phillips, Babak Choodari-Oskooei, Matthew Robert Sydes
Proposals on Kaplan-Meier plots in medical research and a survey of stakeholder views: KMunicate. BMJ open 9 (9) (2019)
Janet Athene Lane, Carrol Gamble, William J Cragg, Doreen Tembo, Matthew Robert Sydes
A third trial oversight committee: Functions, benefits and issues. Clinical trials (London, England) 17 (1) (2019)
Tim Clark, Richard H Wicentowski, Matthew Robert Sydes
Cross-sectional analysis of UK research studies in 2015: results from a scoping project with the UK Health Research Authority. BMJ open 8 (10) (2018)
Sally P Stenning, William J Cragg, Nicola Joffe, Carlos Diaz-Montana, Rahela Choudhury, Matthew Robert Sydes, Sarah Meredith
Triggered or routine site monitoring visits for randomised controlled trials: results of TEMPER, a prospective, matched-pair study. Clinical trials (London, England) 15 (6) (2018)
Duncan C Gilbert, Trinh Duong, Matthew Robert Sydes, Anna Bara, Noel Clarke, Paul Abel, Nicholas D James, Ruth Langley, Max Parmar, null null
Transdermal oestradiol as a method of androgen suppression for prostate cancer within the STAMPEDE trial platform. BJU international 121 (5) (2018)
Clare Gilson, Matthew Robert Sydes, Simon Chowdhury
Will chemotherapy change the management of prostate cancer? BJU international 118 (2) (2016)
Laura Fachal, Antonio Gómez-Caamaño, Gillian C Barnett, Paula Peleteiro, Ana M Carballo, Patricia Calvo-Crespo, Sarah L Kerns, Manuel Sánchez-García, Ramón Lobato-Busto, Leila Dorling, Rebecca M Elliott, David P Dearnaley, Matthew Robert Sydes, Emma Hall, Neil G Burnet, Ángel Carracedo, Barry S Rosenstein, Catharine M L West, Alison M Dunning, Ana Vega
A three-stage genome-wide association study identifies a susceptibility locus for late radiotherapy toxicity at 2q24.1. Nature genetics 46 (8) (2014)

Matthew Robert Sydes.css-eqlu8i{font-size:small;padding-left:4px;} (Matthew R Sydes, Matthew Sydes)

Publication Activity (10 Years)

Top Topics

Top Venues

Matthew Robert Sydes (Matthew R Sydes, Matthew Sydes)